MediPurpose(r), a master distributor and manufacturer of medical products, has announced the United Kingdom’s National Health Service (NHS) has awarded a multiple-year renewal of the current contract to continue providing MediPurpose safety medical products to its U.K. healthcare customers through Smiths Medical, Inc. (SMI).
The renewal also expanded the product offering made available through the NHS by the addition of the MediPurpose babyLance(r) heel incision device.
“We are honored that NHS continues to validate the quality and value of our medical products,” said MediPurpose President and CSO Randy Prather. “Our relationship with NHS has been essential for establishing SurgiLance as a top safety lancet in the U.K., and we look forward to enjoying similar results with babyLance in the U.K.”
“The 510(k) clearances favorably position our safety blood collection devices for U.K. healthcare professionals who are being cautioned about multiple-use lancing devices”
Both SurgiLance and babyLance are single-use blood collection devices. They both have also received U.S. Food and Drug Administration (FDA) 510(k) clearances to be marketed as safety medical products in the United States. Furthermore, babyLance is the first infant heel incision device to receive 510(k) clearance with sharps prevention indications.
“The 510(k) clearances favorably position our safety blood collection devices for U.K. healthcare professionals who are being cautioned about multiple-use lancing devices,” said Prather.
SurgiLance is currently available in six models, ranging from 18-26 gauge and 1.0-2.3 mm penetration depth. babyLance is current available in two models that deliver penetration depths of 0.85 mm and 1.0 mm.
About the NHS Supply Chain
Since its launch in 1948, the NHS has grown to become the world’s largest publicly funded health service.
Created specifically to support the needs of National Health Service hospitals in England, the NHS Supply Chain manages numerous purchasing contracts, which account for a significant proportion of the funds allocated by the National Health Service for purchasing goods and services in the health service.
The NHS Supply Chain provides approximately 600 hospitals in England with a dedicated end-to-end supply chain service. Through logistics, procurement and customer support services, the NHS Supply Chain will help the hospitals it serves to realize nearly an estimated £1 billion in combined savings over the next 10 years.
For more information about babyLance and SurgiLance-including requests for no-cost product samples – please visit http://www.medipurpose.com.
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance(r) heel incision device, SurgiLance(r) safety lancet and MediPlus(tm) advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.
MediPurpose’s Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, readers are encouraged to visit http://www.medipurpose.com.